Movantik 25 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FMZXX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,416
Award facts
- Contract value 100% obligated
- $3,415.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,415.93 by the Defense Logistics Agency on September 9, 2025, for the supply of Movantik 25 mg tablets (30-count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 10, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026.
Movantik (naloxegol) is a peripheral mu-opioid receptor antagonist indicated for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The award represents a routine pharmaceutical supply transaction supporting the Defense Health Agency and the broader military healthcare system's medication inventory. AmerisourceBergen Drug Corp's status as a major pharmaceutical distributor and prime vendor for DLA demonstrates its critical role in supplying diverse therapeutic medications, including specialty pharmaceuticals and brand-name drugs, to support military and veteran healthcare operations. The company's comprehensive federal contract portfolio reflects its established capability to meet federal procurement requirements across multiple medication categories and therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FMZXX?
SPE2DB25FMZXX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FMZXX worth?
The government has obligated $3,416 on SPE2DB25FMZXX.
Is contract SPE2DB25FMZXX an order under another contract?
Yes. SPE2DB25FMZXX is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMZXX competed?
The extent of competition for SPE2DB25FMZXX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award